Aurobindo Pharma subsidiary receives USFDA’s Establishment Inspection Report; stock rises over 4%

The US FDA inspected Aurobindo Pharma’s Andhra Pradesh unit from Sept 13 to 19, 2023

Subscribe To Our Free Newsletter